David A. Ramsay

2012

In 2012, David A. Ramsay earned a total compensation of $530.8K as Vice President and Chief Financial Officer at Halozyme Therapeutics, a 15% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$40,890
Option Awards$159,270
Salary$181,733
Stock Awards$141,125
Other$7,811
Total$530,829

Ramsay received $181.7K in salary, accounting for 34% of the total pay in 2012.

Ramsay also received $40.9K in non-equity incentive plan, $159.3K in option awards, $141.1K in stock awards and $7.8K in other compensation.

Rankings

In 2012, David A. Ramsay's compensation ranked 8,580th out of 11,487 executives tracked by ExecPay. In other words, Ramsay earned more than 25.3% of executives.

ClassificationRankingPercentile
All
8,580
out of 11,487
25th
Division
Manufacturing
3,115
out of 4,253
27th
Major group
Chemicals And Allied Products
832
out of 1,198
31st
Industry group
Drugs
607
out of 920
34th
Industry
Biological Products, Except Diagnostic Substances
99
out of 160
38th
Source: SEC filing on April 3, 2015.

Ramsay's colleagues

We found five more compensation records of executives who worked with David A. Ramsay at Halozyme Therapeutics in 2012.

2012

Gregory Frost

Halozyme Therapeutics

Chief Executive Officer

2012

Kurt Gustafson

Halozyme Therapeutics

Chief Financial Officer

2012

H Shepard

Halozyme Therapeutics

Chief Scientific Officer

2012

James Shaffer

Halozyme Therapeutics

Former Vice President and Chief Commercial Officer

2012

Jean Liu

Halozyme Therapeutics

General Counsel

You may also like